Palbociclib in combination with either aromatase inhibitors or fulvestrant for patients with advanced HR+/HER2- breast cancer in Germany - Final results of the phase 2 multicohort INGE-B trial.
Welslau M, Potthoff K, Zaiss M, Müller L, Brucker C, Salat C, Untch M, Meiler J, Lüftner D, Welt A, Dörfel S, Hagen V, Stein A, Liersch R, Kuhn T, Siebenbach HU, Bing G, Vannier C, Marschner N, Gratzke K.
Welslau M, et al. Among authors: kuhn t.
Oncol Res Treat. 2024 Nov 15:1-20. doi: 10.1159/000542459. Online ahead of print.
Oncol Res Treat. 2024.
PMID: 39551040
Free article.